Loading clinical trials...
Loading clinical trials...
Observational Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Conditions
Interventions
Ultomiris
Locations
7
United States
Research Site
Boston, Massachusetts, United States
Research Site
Melbourne, Victoria, Australia
Research Site
Paris, France
Research Site
Essen, Norte-Westfalia, Germany
Research Site
Rome, Italy
Research Site
Seoul, South Korea
Start Date
December 16, 2024
Primary Completion Date
July 11, 2034
Completion Date
July 11, 2034
Last Updated
April 16, 2026
NCT07197892
NCT07437248
NCT05876312
NCT06965530
NCT07525193
NCT05403632
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions